BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2001
View Archived Issues
Inflazyme and Helicon to study drug leads related to learning and memory
Read More
Bristol-Myers Squibb to conduct Glucovance trial in pediatric type 2 diabetes
Read More
Telik and Sanwa Kagaku extend drug discovery alliance for second time
Read More
Genome Therapeutics to identify DNA map of pathogenic organism for Wyeth Lederle Vaccines
Read More
Aviron highlights Q4 and year-end 2000 developments
Read More
Repligen updates product development programs
Read More
University of Iowa licenses AAV technology to Targeted Genetics
Read More
Schering-Plough identifies novel antifungal agents that damage the fungal cell wall
Read More
Curvularol: a naturally produced cell cycle inhibitor
Read More
In vitro study provides support for development of CS-891 as Rx for alopecia
Read More
Novel vaccine approach warrants further evaluation in pancreatic cancer
Read More
Genta licenses antisense technology to Atugen
Read More
Abgenix and Celltech enter license and codevelopment agreement based on SLAM technology
Read More
Candidate AGE formation inhibitor exhibits renoprotective effects in diabetic rats
Read More
Lundbeck buys out Byk Gulden in German joint venture
Read More
Demegen to expand cancer research
Read More
SCIO-469 now being studied in phase Ib trial for treatment of RA
Read More
Clinical data on BMS-232632 presented at Chicago conference
Read More
Durect setting fast pace in phase II DUROS sufentanil trial for chronic pain
Read More
Avax subsidiary to evaluate TK suicide gene therapy technology
Read More
Phase III trial of irofulven in pancreatic cancer proceeds on schedule
Read More
BCH-10618 shows favorable resistance profile in cell culture experiments
Read More
Preclinical studies point to role for ACH-126443 in combination anti-HIV therapy
Read More
Ivax acquires Lilly's talampanel, an advanced-stage antiepileptic
Read More
Selective Y1 receptor antagonists and their use described by BMS
Read More
Antiviral agents designed at Biota are reportedly superior to pirodavir
Read More
Recent patent covers new antibacterial quinoline derivatives
Read More
Former SmithKline Beecham provides macrophage scavenger receptor antagonists
Read More
ISIS-28030: a new antisense inhibitor of PI3K p85
Read More